Streetbeat News

OHI

Omega Healthcare Investors, Inc.

https://www.omegahealthcare.com

Industry

REIT - Healthcare Facilities

Omega is a real estate investment trust that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the US, as well as in the UK.

Open

N/A

Mkt cap

N/A

Volume

N/A

High

N/A

P/E Ratio

N/A

52-wk high

N/A

Low

N/A

Div yield

N/A

52-wk low

N/A

Omega Healthcare Investors (OHI) has increased its 2024 AFFO guidance to $2.78-$2.84 per diluted share, up from the previous estimate of $2.70-$2.80. This includes $648 million in new investments, quarterly G&A expenses of $11.5M-$13.5M, $77M in asset sales, and timely operator restructurings and transitions.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2024 | 8:37 pm

Omega Healthcare Investors (NYSE: OHI) reported Q2 2024 earnings per share of $0.71, beating the analyst estimate of $0.69. The company also reported sales of $252.75 million, surpassing the $243.04 million estimate. This represents a 1.02% increase over the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2024 | 8:35 pm

Wall Street's most accurate analysts have provided their latest ratings on three high-dividend-yielding real estate stocks: Brandywine Realty Trust (BDN), EPR Properties (EPR), and Omega Healthcare Investors, Inc. (OHI). These stocks are known for their high free cash flows and substantial dividend payouts. Analysts have given mixed ratings and adjusted price targets for these stocks, reflecting their current market conditions and future outlooks.

Portfolio Pulse from Avi Kapoor

July 19, 2024 | 11:50 am

Omega Healthcare Investors, Inc. (NYSE: OHI) has committed $10 million to support LaVie Care Centers during its Chapter 11 bankruptcy. This funding will ensure operational liquidity and maintain quality care at LaVie facilities. Omega expects sustainable cash flow and long-term rent from its LaVie portfolio.

Portfolio Pulse from Benzinga Newsdesk

June 03, 2024 | 12:07 pm

Omega Healthcare Invts (NYSE:OHI) has received mixed analyst ratings over the past three months, with a recent shift towards a more positive outlook. Four analysts have provided ratings, with an updated average 12-month price target of $33.00, up from $31.33. The ratings range from 'Buy' to 'Neutral', with price targets adjusted upwards by analysts from Truist Securities, Citigroup, Wells Fargo, and Exane BNP Paribas. Omega's financial performance shows strong revenue growth, exceptional net margin, and efficient asset and equity management, indicating a positive trend for the company.

Portfolio Pulse from Benzinga Insights

May 06, 2024 | 6:00 pm

JMP Securities analyst Aaron Hecht reiterates a Market Perform rating on Omega Healthcare Invts (OHI), indicating a neutral outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

May 06, 2024 | 3:20 pm

Omega Healthcare Investors, Inc. (OHI) has reaffirmed its adjusted Funds From Operations (FFO) per share outlook for 2024 to be in the range of $2.70-$2.80, aligning closely with the estimated $2.77.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 8:59 pm

Omega Healthcare Invts (NYSE:OHI) reported Q1 2024 Adjusted FFO of $0.68 per share, surpassing the $0.66 estimate, and sales of $243.299M, exceeding the $231.639M estimate. This represents a 3.03% increase in Adjusted FFO and an 11.50% increase in sales year-over-year.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 8:22 pm

Truist Securities analyst Michael Lewis maintains a Hold rating on Omega Healthcare Invts (OHI) and raises the price target from $31 to $32.

Portfolio Pulse from Benzinga Newsdesk

April 02, 2024 | 1:32 pm

Omega Healthcare Invts (NYSE:OHI) has been evaluated by 7 analysts over the last three months, showing a mix of bullish to bearish sentiments. The average 12-month price target for OHI has been raised to $33.14, indicating a slight optimism among analysts. Key financial indicators such as revenue growth, net margin, ROE, and ROA have shown strong performance, although the company faces challenges in debt management.

Portfolio Pulse from Benzinga Insights

March 22, 2024 | 1:00 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.